Industries

Pipeline Generation for Medical Device CDMOs

Medical device CDMOs win programs at a specific moment: when a device company freezes a design, clears the FDA or raises money to scale. XO Medtech Sales Intelligence watches for those moments across emerging and mid-sized device companies and strategic OEM divisions, scores each against your design, manufacturing and regulatory capabilities, and delivers the decision-makers and drafted outreach.

Why generic sales tools miss medical device CDMOs

A medical device CDMO sells design, manufacturing and regulatory work, and a device company buys each of those at a different point in its program. Contact databases sort companies by industry code, headcount and location. In those filters, a 30-person catheter company that froze its design last month looks the same as one that stalled two years ago.

The word CDMO adds its own noise. It is used across pharma, so a search for CDMO prospects in a general data tool often returns drug and biologics developers next to the device companies you want.

The buyer also moves during a program. R&D leaders pick a development partner, operations takes over at transfer, and regulatory weighs in before the submission. One VP name per account misses most of the people who decide.

Buying triggers for medical device CDMOs

Six of the 12 signals in our buying signals guide matter most to a full-service CDMO.

  • 510(k) or De Novo clearance

    A first clearance means the design is locked and the company has to get from pilot lots to launch volume with a supply chain that passes an audit. The FDA 510(k) and De Novo databases list it by decision date and product code.

  • IDE approval or pivotal trial start

    Someone has to build the clinical units under design controls, and the team that builds them is best placed for the commercial transfer. ClinicalTrials.gov shows industry-sponsored device studies as they open for recruiting.

  • Breakthrough Device designation

    A designated device has years of design iteration ahead, which is when design-for-manufacturing help pays off most. Designations surface in company press releases and trade press, since FDA generally does not disclose them before marketing authorization.

  • A Series B or C that names launch

    A round raised for commercialization or scale-up is money set aside for building product. The Form D on SEC EDGAR shows the raise, and the company's announcement says what the money is for.

  • An OEM buys a device startup

    The acquirer has to decide where the acquired product gets made, and that question stays open until the integration plan is written. Acquirer press releases and 8-K filings show the deal first.

  • A new VP of Operations

    A new operations leader reviews the supplier base in the first few months, before owning its problems. When it is the company's first operations hire, production at volume is usually close.

"Using Campaigns to do outreach for the LSI 2026 show was so easy it felt like a cheat code. Having research on all the attendees saved me so much time. Did outreach to 70+ companies, took 2 hours, ended up booking 8 meetings. So crazy!"

Sam W.Business Development Executive at a CDMO

Built for medical device CDMO teams

  • Accounts scored against your capabilities

    Campaigns finds and qualifies emerging and mid-sized device companies and scores each against what you design, build and file, so a program that needs development help and one ready for transfer are easy to tell apart.

  • Signals from device records

    Accounts are found and qualified with FDA clearances, clinical trials, patents, grants, funding and hiring, the records that show where a device program stands.

  • Several decision-makers per account

    Campaigns sources several decision-makers at each company, so your team can reach the R&D, operations and regulatory leaders who each own part of the CDMO decision.

  • Strategic OEMs, division by division

    Org Map breaks one strategic OEM into its divisions and names the 10 to 15 decision-makers in each, with a Strategic Account Plan for the account.

  • Drafted outreach in your CRM

    Campaigns drafts the outreach and enrolls contacts in sequences in your CRM, so reps start on accounts without re-entering data.

  • Research done for your team

    XO Medtech is software as a managed service. Its agents and analysts do the research and list building, and your business development team works from a dashboard.

Frequently asked questions

Talk to us about CDMO pipeline

Bring the device programs you want to win and the design, manufacturing and regulatory work you sell.